Fecal carriage of extended-spectrum β-lactamases and AmpC-producing Escherichia coli in a Libyan community

Annals of Clinical Microbiology and Antimicrobials

Volumn 13, Issue 1, 2014, Pages

  Ahmed, Salwa F ^a   Ali, Mostafa Mohamed M ^b   Mohamed, Zienat K ^c   Moussa, Tarek A ^c   Klena, John D ^a  

^a US Naval Medical Research Unit No 3 Egypt   (Egypt)

^b UNIVERSITY OF TRIPOLI   (Libyan Arab Jamahiriya)

^c CAIRO UNIVERSITY   (Egypt)

Author keywords

AmpC; CTXM; E. coli; ESBLs; Fecal carriage; Libya; MLST

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; BACTERIAL DNA; BETA LACTAMASE AMPC; BORONIC ACID DERIVATIVE; CEFALOTIN; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; CHLORAMPHENICOL; CIPROFLOXACIN; CLAVULANIC ACID; COTRIMOXAZOLE; IMIPENEM; NALIDIXIC ACID; STREPTOMYCIN; SULTAMICILLIN; TETRACYCLINE; BETA LACTAMASE; BETA LACTAMASE CTX M; CEPHALOSPORIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL VIRULENCE; BACTERIUM CARRIER; BACTERIUM ISOLATE; CHILD; CONTROLLED STUDY; DISK DIFFUSION; DNA SEQUENCE; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ESCHERICHIA COLI; FECAL CARRIAGE; FECES; FECES MICROFLORA; GENETIC CODE; HUMAN; LIBYAN ARAB JAMAHIRIYA; MAJOR CLINICAL STUDY; MOLECULAR PHYLOGENY; MOLECULAR TYPING; MULTIGENE FAMILY; MULTILOCUS SEQUENCE TYPING; NONHUMAN; PHENOTYPE; CLASSIFICATION; COMMUNITY ACQUIRED INFECTION; ENZYMOLOGY; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; GENETICS; GENOTYPE; HETEROZYGOTE; ISOLATION AND PURIFICATION; MALE; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MOLECULAR EPIDEMIOLOGY; PRESCHOOL CHILD; PREVALENCE; PULSED FIELD GEL ELECTROPHORESIS; SECRETION (PROCESS); ANTIBIOTIC SENSITIVITY; BACTERIAL STRAIN; BACTERIUM ISOLATION; BETA LACTAMASE AMPC ESCHERICHIA COLI; LIBYAN;

BETA-LACTAMASES; CARRIER STATE; CHILD; CHILD, PRESCHOOL; COMMUNITY-ACQUIRED INFECTIONS; ELECTROPHORESIS, GEL, PULSED-FIELD; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FECES; FEMALE; GENOTYPE; HUMANS; LIBYA; MALE; MICROBIAL SENSITIVITY TESTS; MOLECULAR EPIDEMIOLOGY; MULTILOCUS SEQUENCE TYPING; PREVALENCE;

EID: 84904622895     PISSN: None     EISSN: 14760711     Source Type: Journal    
DOI: 10.1186/1476-0711-13-22     Document Type: Article

References (41)

1. Coque TM, Novais A, Carattoli A, Poirel L, Pitout J, Peixe L, Baquero F, Cantón R, Nordmann P. Dissemination of clonally related Escherichia coli strains expressing extended-spectrum β-lactamase CTX-M-15. Emerg Infect Dis 2008, 14:195-200.
2. Novais A, Cantón R, Valverde A, Machado E, Galán JC, Peixe L, Carattoli A, Baquero F, Coque TM. Dissemination and persistence of blaCTX-M-9 are linked to class 1 integrons containing CR1 associated with defective transposon derivatives from Tn402 located in early antibiotic resistance plasmids of IncHI2, IncP1-α, and IncFI groups. Antimicrob Agents Chemother 2006, 50:2741-2750.
3. Bonnet R. Growing group of extended-spectrum b-lactamases: the CTX-M enzymes. Antimicrob Agents Chemother 2004, 48:1-14.
4. Canton R, Coque TM. The CTX-M β-lactamase pandemic. Curr Opin Microbiol 2006, 9:466-475.
5. Pitout JD, Nordmann P, Laupland KB, Poirel L. Emergence of Enterobacteriaceae producing extended-spectrum β-lactamases (ESBLs) in the community. J Antimicrob Chemother 2005, 56:52-59.
6. Elaldi N1, Gozel MG, Kolayli F, Engin A, Celik C, Bakici MZ, Vahaboglu H. Community-acquired CTX-M-15-type ESBL-producing Escherichia coli meningitis: a case report and literature review. J Infect Dev Ctries 2013, 13:424-431.
7. Moland ES, Black JA, Hossain A, Hanson ND, Thomson KS, Pottumarthy S. Discovery of CTX-M-like extended-spectrum beta-lactamases in Escherichia coli isolates from five U.S. states. Antimicrob Agents Chemother 2003, 47:2382-2383.
8. Woerther PL, Burdet C, Chachaty E, Andremont A. Trends in human fecal carriage of extended- spectrum β-lactamases in the community:toward the globalization of CTX-M. Clin Microbiol Rev 2013, 26:744-758.
9. Luvsansharav U-O, Hirai I, Nakata A, Imura K, Yamauchi K, Niki M, Komalamisra C, Kusolsuk T, Yamamoto Y. Prevalence of and risk factors associated with faecal carriage of CTX-M β-lactamase-producing Enterobacteriaceae in rural Thai communities. J Antimicrob Chemother 2012, 67:1769-1774.
10. Birgy A, Cohen R, Levy C, Bidet P, Courroux C, Benani M, Thollot F, Bingen E. Community faecal carriage of extended-spectrum beta-lactamase-producing Enterobacteriaceae in french children. BMC Infect Dis 2012, 12:1-5.
11. Dahmen S, Bettaieb D, Mansour W, Boujaafar N, Bouallegue O, Arlet G. Characterization and molecular epidemiology of extended-spectrum β-lactamases in clinical isolates of Enterobacteriaceae in a Tunisian University hospital. Microb Drug Resist 2010, 16:163-170.
12. Moubareck C, Daoud Z, Hakime NI, Hamze M, Mangeney N, Matta H, Mokhbat JE, Rohban R, Sarkis DK, Doucet-Populaire D. Countrywide spread of community- and hospital-acquired extended-spectrum -lactamase (CTX-M-15)-producing Enterobacteriaceae in Lebanon. J Clin Microbiol 2005, 43:3309-3313.
13. Li B, Sun JY, Liu QZ, Han LZ, Huang XH, Ni YX. High prevalence of CTX-M β-lactamases in faecal Escherichia coli strains from healthy humans in Fuzhou, China. Scand J Infect Dis 2011, 43:170-174.
14. Pallecchi L, Bartoloni A, Fiorelli C, Mantella A, Di Maggio T, Gamboa H, Gotuzzo E, Kronvall G, Paradisi F, Rossolini GM. Rapid dissemination and diversity of CTX-M extended-spectrum β-lactamase genes in commensal Escherichia coli isolates from healthy children from low-resource settings in Latin America. Antimicrob Agents Chemother 2007, 51:2720-2725.
15. Ben Sallem R, Ben Slama K, Estepa V, Jouini A, Gharsa H, Klibi N, Sáenz Y, Ruiz-Larrea F, Boudabous A, Torres C. Prevalence and characterisation of extended-spectrum β -lactamase (ESBL)-producing Escherichia coli isolates in healthy volunteers in Tunisia. Eur J Clin Microbiol Infect Dis 2012, 31:1511-1516.
16. Luvsansharav UO, Hirai I, Niki M, Sasaki T, Makimoto K, Komalamisra C, Maipanich W, Kusolsuk T, Sa-Nguankiat S, Pubampen S, Yamamoto Y. Analysis of risk factors for a high prevalence of extended-spectrum β -lactamase-producing Enterobacteriaceae in asymptomatic individuals in rural Thailand. J Med Microbiol 2011, 60:619-624.
17. Abdul Rahman EM, El-Sherif RH. High rates of intestinal colonization with extended-spectrum lactamase-producing Enterobacteriaceae among healthy individuals. J Invest Med 2011, 59:1284-1286.
18. Hollander R, Ebke M, Barck H, von Pritzbuer E. Asymptomatic carriage of Klebsiella pneumoniae producing extended-spectrum β-lactamase by patients in a neurological early rehabilitation unit: management of an outbreak. J Hosp Infect 2001, 48:207-213.
19. Bonomo RA, Donskey CJ, Blumer JL, Hujer AM, Hoyenm CK, Jacobs MR, Whalen CC, Salata RA. Cefotaxime-resistant bacteria colonizing older people admitted to an acute care hospital. J Am Geriatr Soc 2003, 51:519-522.
20. Mirellis B, Navarro F, Miró E, Mesa RJ, Coll P, Prats G. Community transmission of extended spectrum Beta-lactamases. Emerg Infect Dis 2003, 9:1024-1025.
21. Clinical and Laboratory Standards Institute Performance Standards for Antimicrobial Susceptibility Testing; Twenty First informational Supplement, CLSI document M 100-S21 2011, Wayne, PA; USA: Clin and Lab standards Institute, Clinical and Laboratory Standards Institute.
22. Jarlier V, Nicolas MH, Fournier G, Philippon A. Extended broad-spectrum b-lactamases conferring transferable resistance to newer β-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns. Rev Infect Dis 1988, 10:867-878.
23. Fam N, Gamal D, El Said M, Abou-Fadl L, El Dabei E, El Attar S, Sorur A, Fouad S, Klena J. Detection of plasmid-Mediated AmpC Beta-lctamass in clinically significant bacterial isolates in a research institute hospital in Egypt. Life Sci J 2013, 10:2294-2302.
24. Newire EA, Ahmed SF, House B, Valiente E, Pimentel G. Detection of new SHV-12, SHV-5 and SHV-2a variants of extended spectrum Beta-lactamase in Klebsiella pneumoniae in Egypt. Ann Clin Microbiol Antimicrob 2013, 12:1-12.
25. Chen S, Zhao S, White DG, Schroeder CM, Lu R, Yang H, McDermott PF, Ayers SJ, Meng J. Characterization of multiple-antimicrobial-resistant Salmonella serovars isolated from retail meats. Appl Environ Microbiol 2004, 70:1-7.
26. Clermont O, Bonacorsi S, Bingen E. Rapid and simple determination of the Escherichia coli phylogenetic group. Appl Environ Microbiol 2000, 66:4555-4558.
27. Wirth T, Falush D, Lan R, Colles F, Mensa P, Wieler LH, Karch H, Reeves PR, Maiden MC, Ochman H, Achtman M. Sex and virulence in Escherichia coli: an evolutionary perspective: Mol. Microbiol 2006, 60:1136-1151.
28. PulseNet USA: One-Day (24-28h) Standardized laboratory protocol for molecular subtyping of Escherichia coli O157:H7, Salmonella serotypes, and Shigella sonnei by Pulsed Field Gel Electrophoresis (PFGE). Pulse Net Internat. 2009. http://www.pulsenetinternational.org/assets/PulseNet/uploads/pfge/PNL05_Ec-Sal-ShigPFGEprotocol.pdf, PulseNet USA: One-Day (24-28h).
29. Ali MMM, Mohamed ZK, Klena JD, Ahmed SF, Moussa TAA, Ghenghesh KS. Molecular characterization of Diarrheagenic Escherichia coli from Libya. Am J Trop Med Hyg 2012, 86:866-871.
30. Kader AA, Kumar A, Kamath KA. Fecal carriage of extended-spectrum b-lactamase-producing Escherichia coli and Klebsiella pneumoniae in patients and asymptomatic healthy individuals. Infect Control Hosp Epidemiol 2007, 28:1114-1116.
31. Luvsansharav UO, Hirai I, Niki M, Nakata A, Yoshinaga A, Moriyama T, Yamamoto Y. Prevalence of fecal carriage of extended-spectrum β -lactamase-producing Enterobacteriaceae among healthy adult people in Japan. J Infect Chemother 2011, 17:722-725.
32. Leflon-Guibout V, Blanco J, Amaqdouf K, Mora A, Guize L, Nicolas-Chanoine MH. Absence of CTX-M enzymes but high prevalence of clones, including clone ST131, among fecal Escherichia coli isolates from healthy subjects living in the area of Paris, France. J Clin Microbiol 2008, 46:3900-3905.
33. Rossi F, Baquero F, Hsueh PR, Paterson DL, Bochicchio GV, Snyder TA, Satishchandran V, McCarroll K, DiNubile MJ, Chow JW. In vitro susceptibilities of aerobic and facultatively anaerobic Gram-negative bacilli isolated from patients with intra-abdominal infections worldwide: 2004 results from SMART (Study for Monitoring Antimicrobial Resistance Trends). J Antimicrob Chemother 2006, 58:205-210.
34. Nicolas-Chanoine MH, Coraline Gruson C, Bialek-Davene S, Bertrand X, Thomas-Jean F, Bert F, Moyat M, Meiller E, Marcon E, Danchin N, Noussair L, Moreau R, Leflon-Guibout V. 10-Fold increase (2006-11) in the rate of healthy subjects with extended-spectrum β -lactamase-producing Escherichia coli faecal carriage in a Parisian check-up centre. J Antimicrob Chemother 2013, 68:562-568.
35. Cortés P, Blanc V, Mora A, Dahbi G, Blanco JE, Blanco M, López C, Andreu A, Navarro F, Alonso MP, Bou G, Blanco J, Llagostera M. Isolation and characterization of potentially pathogenic antimicrobial-resistant Escherichia coli strains from chicken and pig farms in Spain. Appl Environ Microbiol 2010, 76:2799-2805.
36. Girlich D, Poirel L, Carattoli A, Kempf I, Lartigue MF, Bertini A, Nordmann P. Extended-spectrum β -lactamase CTX-M-1 in Escherichia coli isolates from healthy poultry in France. Appl Environ Microbiol 2007, 73:4681-4685.
37. Pitout JD, Laupland KB. Extended spectrum β-lactamases producing Enterobacteriaceae: an emerging public-health concern. Lancet Infect Dis 2007, 8:159-166.
38. Morosini MI, García-Castillo M, Coque TM, Valverde A, Novais A, Loza E, Baquero F, Cantón R. Antibiotic coresistance in extended-spectrum-β-lactamase-producing Enterobacteriaceae and in vitro activity of tigecycline. Antimicrob Agents Chemother 2006, 50:2695-2699.
39. Yu HS, Lee JC, Kang HY, Jeong YS, Lee EY, Choi CH, Tae SH, Lee YC, Seol SY, Cho DT. Prevalence of dfr genes associated with integrons and dissemination of dfrA17 among urinary isolates of Escherichia coli in Korea. J Antimicrob Chemother 2013, 53(3):445-450.
40. Fam NS, El-Damarawy MM. CTX-M15 extended-spectrum-β-lactamase detected from intensive care unit of an Egyptian medical research institute. Res J Med Sci 2008, 3:84-91.
41. Gijón D, Curiao T, Baquero F, Coque TM, Cantón R. Fecal carriage of carbapenemase-producing Enterobacteriaceae: a hidden reservoir in hospitalized and nonhospitalized patients. J Clin Microbiol 2012, 50(5):1558-1563.